Previous close | 0.7800 |
Open | 0.7650 |
Bid | 0.8609 x 800 |
Ask | 0.9100 x 800 |
Day's range | 0.7600 - 0.8662 |
52-week range | 0.2900 - 2.0000 |
Volume | |
Avg. volume | 2,259,785 |
Market cap | 152.249M |
Beta (5Y monthly) | 1.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4800 |
Earnings date | 24 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.17 |
Sangamo Therapeutics ( NASDAQ:SGMO ) Full Year 2023 Results Key Financial Results Revenue: US$176.2m (up 58% from FY...
Q4 2023 Sangamo Therapeutics Inc Earnings Call
RICHMOND, Calif., March 13, 2024--Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results